What's new

EMEA-001222-PIP01-11-M01

EMEA-001222-PIP01-11-M01

Jun 24, 2025 - 17:50
 0
EMEA-001222-PIP01-11-M01
EMEA-001222-PIP01-11-M01
Read More

Tags:

Previous Article

STAT+: Radical transparency at the FDA, and a pivotal moment for vaccines

Next Article

Opinion/decision on a Paediatric investigation plan (PIP): Constella, linaclotid...

Related Posts

Human medicines European public assessment report (EPAR): Doptelet, avatrombopag, Date of authorisation: 20/06/2019, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 18, 2025  0

Human medicines European public assessment report (EPAR): Apexelsin, paclitaxel, Date of authorisation: 24/07/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 10, 2025  0

Orphan designation: Tertomotide Treatment of progressive supranuclear palsy, 22/05/2025 Positive

Orphan designation: Tertomotide Treatment of progressiv...

Jun 24, 2025  0